Table 3

Summary statistics to assess binary liver enzymes in predicting incident T2D

VariableBest cut-offsMultivariable model
Discrimination (AUC (95% CI))Calibration (AIC)NRIIDI
Base model0.74 (0.71 to 0.77)1394
ALT210.75 (0.73 to 0.78)*13700.530.02
Base model0.76 (0.72 to 0.80)613
GGT230.77 (0.73 to 0.81)†6090.410.01
Base model0.76 (0.72 to 0.80)613
ALT+GGT0.77 (0.73 to 0.81)†609
  • Base model included education level (no, primary school, secondary and above), weekly moderate-to-vigorous activity (<0.5, 0.5–3.9, and ≥4 hours/week), history of hypertension (yes, no), plasma concentrations of triglycerides (mmol/L) (tertiles) and high-density lipoprotein cholesterol (mmol/L) (tertiles), and BMI (continuous).

  • Multivariable model adjusted for all the variables included in the base model.

  • *ALT concentrations were measured in 1142 participants (571 case–control pairs). Compared with the base model, the increment in AUC value was statistically significant (p<0.05).

  • †GGT concentrations were measured in 510 participants (255 case–control pairs with cases having baseline HbA1c <48 mmol/mol (6.5%)). Compared with the base model (AUC, 0.76 (0.72–0.80)), increment in AUC value by adding GGT to the base model was not significant (p=0.36). Additionally, increment in AUC value by adding GGT together with ALT to the base model was not significant either (p=0.20).

  • AIC, Akaike information criterion; ALT, alanine aminotransferase; AUC, area under ROC curve; BMI, body mass index; GGT, γ-glutamyl transferase; IDI, integrated discrimination improvement; NRI, net reclassification improvement; T2D, type 2 diabetes.